Skip to main content
. 2016 Jul 13;53(2):547–556. doi: 10.3233/JAD-160258

Table 2.

Cognitive Test Scores at the time of PiB PET imaging

Cognitive scoresa Oral CEE (N = 17) Transdermal 17β-Estradiol (N = 21) Placebo (N = 30) p-valuesb
NYU Paragraph Immediate Recall Total Score 25 (16, 33) 26 (15, 39) 24 (17, 40) 0.86
NYU Delayed Recall Total Score 16 (5, 24) 14 (7, 23) 14 (9, 32) 0.88
CVLT-II Trials 1–3 Total Score 29 (16, 36) 33 (25, 42) 31 (14, 43) 0.03*
CVLT-II Trial Short Delay Free Recall score 10 (3, 16) 12 (7, 16) 11 (4, 16) 0.06
CVLT-II Trial Long Delay Free Recall score 9 (3, 15) 11 (6, 15) 10 (4, 16) 0.19
WMS-III Digit Span Total Score 15 (10, 22) 18 (10, 26) 17 (8, 26) 0.20
WMS-III Letter Number Sequencing Trial Total Score 10 (6, 14) 11 (6, 15) 10 (7, 17) 0.50
Trail Making Test A (Time to complete in seconds) 24 (15, 44) 23 (15, 43) 24 (15, 39) 0.89
Trail Making Test B (Time to complete in seconds) 56 (33, 83) 59 (35, 249) 57 (33, 135) 0.85
Phonemic Fluency (F,A,S) Total Score 44 (27, 69) 43 (19, 59) 46 (22, 77) 0.40
Semantic Fluency (animals, fruits, vegetables) Total Score 56 (30, 77) 55 (38, 68) 52 (36, 71) 0.35
Stroop Trial Word 99 (69, 136) 105 (70, 120) 100 (69, 140) 0.95
Stroop Trial Color 78 (61, 96) 74 (60, 110) 75 (58, 101) 0.55
Stroop Trial Color-Word 43 (18, 58) 44 (31, 61) 46 (21, 78) 0.78
Digit Symbol Total Score 82 (57, 93) 83 (61, 108) 82 (64, 103) 0.09

aData shown are median (range) of raw scores. bp-values were assessed using Analysis of Variance adjusting for age at PiB PET, levels of education, time from menopause to randomization (months) and APOE ɛ4 carrier status. *Tukey Honest significant differences test for post hoc comparisons: Oral CEE versus placebo (p = 0.03); CEE versus transdermal17β-estradiol (p = 0.08); transdermal17β-estradiol versus placebo (p = 0.98).